Defined Wealth Management’s Pfizer PFE Stock Holding History

Defined Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,218	Closed	-$206K	–	100
2023 Q3	$206K	Buy	6,218 +161	+3%	+$5.69K	0.18%	98
2023 Q2	$222K	Buy	6,057 +23	+0.4%	+$895	0.19%	96
2023 Q1	$246K	Buy	6,034 +500	+9%	+$21.6K	0.23%	91
2022 Q4	$284K	Hold	5,534	–	–	0.27%	85
2022 Q3	$242K	Hold	5,534	–	–	0.26%	79
2022 Q2	$290K	Hold	5,534	–	–	0.3%	75
2022 Q1	$286K	Hold	5,534	–	–	0.25%	85
2021 Q4	$327K	Hold	5,534	–	–	0.27%	78
2021 Q3	$238K	Buy	5,534 +50	+0.9%	+$2.21K	0.21%	88
2021 Q2	$215K	Buy	+5,484	New	+$213K	0.19%	91
2021 Q1	–	Sell	-5,484	Closed	-$202K	–	166
2020 Q4	$202K	Buy	+5,484	New	+$201K	0.2%	89

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Defined Wealth Management's PFE Position: Q4 2023 in Review

Defined Wealth Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,218 shares — an estimated $206K sold.

Defined Wealth Management first reported a position in PFE in Q4 2020 and held it in 11 quarters. The position peaked at $327K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Defined Wealth Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Defined Wealth Management sold 6,218 Pfizer shares in Q4 2023, an estimated $206K.
Defined Wealth Management first reported a position in Pfizer in Q4 2020 and held it in 11 quarters.
Defined Wealth Management's Pfizer position peaked at $327K in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Defined Wealth Management's 13F filing for Q4 2023, filed 9 Jan 2024.